Difference between revisions of "MAM-2201"
(Created page with "'''MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122)''' is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been report...") |
(No difference)
|
Latest revision as of 04:56, 15 February 2015
MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in Synthetic Cannabis smoking blends.Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries. MAM-2201 has been banned by being added to the temporary class drug schedule in New Zealand, effective from 13 July 2012.
